Renal toxicity of contrast agents: iopamidol, iothalamate, and diatrizoate
- 1 February 1984
- journal article
- research article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 142 (2) , 333-335
- https://doi.org/10.2214/ajr.142.2.333
Abstract
As part of a general safety study of iopamidol, a nonionic iodinated contrast agent, urine N-acetyl-beta-glucosaminidase enzyme assays were done to compare the renal toxicity of iopamidol with that of iothalamate and diatrizoate. In a randomized study of 30 patients for computed body tomography and another 30 patients for angiography, 10 in each group were injected with iopamidol, 10 with iothalamate, and 10 with diatrizoate. After computed tomography or angiography with the three agents, there was no significant difference in urinary enzyme levels among the groups. The nephrotoxicity of iopamidol appears equivalent to that of diatrizoate and iothalamate.This publication has 5 references indexed in Scilit:
- Aminoglycoside Nephrotoxicity and its PredictabilityNephron, 1981
- Osmolality of intravascular radiological contrast mediaThe British Journal of Radiology, 1980
- The use of urinary N-acetyl-β-glucosaminidase in human renal toxicology I. Partial biochemical characterization and excretion in humans and release from the isolated perfused rat kidneyToxicology and Applied Pharmacology, 1979
- Salicylate-induced enzymuriaThe American Journal of Medicine, 1978
- ENZYMURIA AS A MARKER OF RENAL INJURY AND DISEASE - STUDIES OF N-ACETYL-BETA-GLUCOSAMINIDASE IN GENERAL POPULATION AND IN PATIENTS WITH RENAL-DISEASE1978